Results 311 to 320 of about 53,857 (331)

Translocator Protein (18 kDa) as a Target for Novel Anxiolytics with a Favourable Side‐Effect Profile

Journal of neuroendocrinology, 2012
C. Nothdurfter, G. Rammes, T. Baghai, C. Schüle, M. Schumacher, V. Papadopoulos, R. Rupprecht   +6 more
semanticscholar   +1 more source

Novel non-benzodiazepine anxiolytics

Neuropharmacology, 1983
J B Patel, J B Malick, M E Goldberg
exaly  

Anxiolytics and Sedatives and Risk of Fractures: Effects of Half-life

Calcified Tissue International, 2008
Peter Vestergaard, Lars Rejnmark, Vestergaard Peter   +2 more
exaly  

Use of Benzodiazepines, Hypnotics, and Anxiolytics in Major Depressive Disorder: Association With Chronic Pain Diseases

Journal of Nervous and Mental Disease, 2010
Xianchen Liu, W. Ye, P. Watson, P. Tepper   +3 more
semanticscholar   +1 more source

Quality of life and social determinants of anxiolytics and hypnotics use in women in Poland: A population-based study

International Journal of Social Psychiatry, 2013
Emilia Kolarzyk, Jerzy T Marcinkowski
exaly  

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Journal of Neuroscience Methods, 1985
S. Pellow, P. Chopin, S. File, M. Briley
semanticscholar   +1 more source

Altered response to benzodiazepine anxiolytics in mice lacking GABAB(1) receptors

European Journal of Pharmacology, 2004
Cedric Mombereau, Klemens Kaupmann, Herman Van Der Putten   +2 more
exaly  

[Anxiolytics].

Ryoikibetsu shokogun shirizu, 2003
Saori, Yamashita, Ikuo, Kudo, Akihiko, Oshima, Ikuo, Kudo   +3 more
openaire   +1 more source

Anxiolytics

2019
openaire   +1 more source

Anxiolytics

2014
D. Fuentes, S.D. Ray, C.P. Holstege
openaire   +1 more source